Hepatobiliary Imaging in Liver-directed Treatments

Caren van Roekel; Margot T.M. Reinders; Sandra van der Velden; Marnix G.E.H. Lam; Manon N.G.J.A. Braat

doi:10.1053/j.semnuclmed.2019.01.007

Hepatobiliary Imaging in Liver-directed Treatments

Caren van Roekel, Margot T.M. Reinders, Sandra van der Velden, Marnix G.E.H. Lam, Manon N.G.J.A. Braat^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

1 Citation (Scopus)

Abstract

Hepatobiliary scintigraphy (HBS) is an emerging tool in the assessment of hepatic function. This nuclear imaging technique can be used to calculate both global and regional liver function. It has proven to be the most reliable way of assessing the distribution of liver function, especially in patients with impaired liver function due to, for example, cirrhosis or after chemotherapy. There are two types of tracers: Technetium-99m with a type of iminodiacetic acid and Technetium-99m galactosyl human serum albumin. The main indication for HBS is the assessment of the future liver remnant function in patients scheduled to undergo hemihepatectomy; to predict the risk of posthepatectomy liver failure. Another upcoming indication is the use of HBS in patients undergoing radioembolization.

Original language	English
Pages (from-to)	227-236
Number of pages	10
Journal	Seminars in nuclear medicine
Volume	49
Issue number	3
DOIs	https://doi.org/10.1053/j.semnuclmed.2019.01.007
Publication status	Published - 1 May 2019

Keywords

Biliary Tract/diagnostic imaging
Humans
Liver/diagnostic imaging
Radionuclide Imaging/methods
Radiotherapy, Image-Guided
Surgery, Computer-Assisted

Access to Document

10.1053/j.semnuclmed.2019.01.007

Cite this

@article{a41ef8758a3b4b42838e949eb77a7c32,

title = "Hepatobiliary Imaging in Liver-directed Treatments",

abstract = "Hepatobiliary scintigraphy (HBS) is an emerging tool in the assessment of hepatic function. This nuclear imaging technique can be used to calculate both global and regional liver function. It has proven to be the most reliable way of assessing the distribution of liver function, especially in patients with impaired liver function due to, for example, cirrhosis or after chemotherapy. There are two types of tracers: Technetium-99m with a type of iminodiacetic acid and Technetium-99m galactosyl human serum albumin. The main indication for HBS is the assessment of the future liver remnant function in patients scheduled to undergo hemihepatectomy; to predict the risk of posthepatectomy liver failure. Another upcoming indication is the use of HBS in patients undergoing radioembolization.",

keywords = "Biliary Tract/diagnostic imaging, Humans, Liver/diagnostic imaging, Radionuclide Imaging/methods, Radiotherapy, Image-Guided, Surgery, Computer-Assisted",

author = "{van Roekel}, Caren and Reinders, {Margot T.M.} and {van der Velden}, Sandra and Lam, {Marnix G.E.H.} and Braat, {Manon N.G.J.A.}",

year = "2019",

month = may,

day = "1",

doi = "10.1053/j.semnuclmed.2019.01.007",

language = "English",

volume = "49",

pages = "227--236",

journal = "Seminars in nuclear medicine",

issn = "0001-2998",

publisher = "W.B. Saunders",

number = "3",

}

TY - JOUR

T1 - Hepatobiliary Imaging in Liver-directed Treatments

AU - van Roekel, Caren

AU - Reinders, Margot T.M.

AU - van der Velden, Sandra

AU - Lam, Marnix G.E.H.

AU - Braat, Manon N.G.J.A.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Hepatobiliary scintigraphy (HBS) is an emerging tool in the assessment of hepatic function. This nuclear imaging technique can be used to calculate both global and regional liver function. It has proven to be the most reliable way of assessing the distribution of liver function, especially in patients with impaired liver function due to, for example, cirrhosis or after chemotherapy. There are two types of tracers: Technetium-99m with a type of iminodiacetic acid and Technetium-99m galactosyl human serum albumin. The main indication for HBS is the assessment of the future liver remnant function in patients scheduled to undergo hemihepatectomy; to predict the risk of posthepatectomy liver failure. Another upcoming indication is the use of HBS in patients undergoing radioembolization.

AB - Hepatobiliary scintigraphy (HBS) is an emerging tool in the assessment of hepatic function. This nuclear imaging technique can be used to calculate both global and regional liver function. It has proven to be the most reliable way of assessing the distribution of liver function, especially in patients with impaired liver function due to, for example, cirrhosis or after chemotherapy. There are two types of tracers: Technetium-99m with a type of iminodiacetic acid and Technetium-99m galactosyl human serum albumin. The main indication for HBS is the assessment of the future liver remnant function in patients scheduled to undergo hemihepatectomy; to predict the risk of posthepatectomy liver failure. Another upcoming indication is the use of HBS in patients undergoing radioembolization.

KW - Biliary Tract/diagnostic imaging

KW - Humans

KW - Liver/diagnostic imaging

KW - Radionuclide Imaging/methods

KW - Radiotherapy, Image-Guided

KW - Surgery, Computer-Assisted

UR - http://www.scopus.com/inward/record.url?scp=85061671265&partnerID=8YFLogxK

U2 - 10.1053/j.semnuclmed.2019.01.007

DO - 10.1053/j.semnuclmed.2019.01.007

M3 - Review article

C2 - 30954189

AN - SCOPUS:85061671265

SN - 0001-2998

VL - 49

SP - 227

EP - 236

JO - Seminars in nuclear medicine

JF - Seminars in nuclear medicine

IS - 3

ER -

Hepatobiliary Imaging in Liver-directed Treatments

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this